“Convergence science has advanced across many fronts, from nanotechnology to regenerative tissue,” says Nobel Laureate Phil Sharp of MIT. “But the funding allocated for convergence research in biomedical science is small and needs to be expanded. In fact, there is no federal agency with the responsibility to fund convergence in biomedical research.”
Four Boston area Israeli collaborations receive $1.3 in funding for innovative medical and energy projects under new MA/Israel partnership.
Anita Harris of New Cambridge Observer writes that Ariana Pharma opens Ariana Data Intelligence, Inc., in Cambridge. Ariana offers “KEM” non-statistical analysis technology to streamline and to cut financial risk of clinical trials.
New Cambridge Observer’s Anita Harris on BIO-IT World 2012, describing the promise and problems presented by burgeoning of health care data.
In a recent talk, MIT Institute Professor Bob Langer described the difficulties he faced in his early career. For job hunters out there the message is simple but profound. Believe in yourself and your ideas, treat people kindly, and keep on going.
Great talk, Bob. Once again, bravo.
A meta-analysis and four additional studies published in the March 2009 Heart Rhythm journal show clearly that Cambridge Heart’s non-invasive MTWA test can accurately predicts the risk of sudden cardiac arrest–the leading killer in the US.
ScientiaNET, Scientia Advisors’ new knowledge network, now 10 thousand strong, is accepting new member/experts and clients for life science consultation, surveys, and opinions.
Scientia Advisors is offering five free Webinars for anyone interested in trends in the health care and life science industries.
